Comparison of omeprazole, metronidazole and clarithromycin with omeprazole/amoxicillin dual-therapy for the cure of Helicobacter pylori infection

Episode von Medizin - Open Access LMU - Teil 12/22 von Ludwig-Maximilians-Universität München · 1. Januar 1998

In this randomized, multicenter trial, we evaluated the effectiveness and side effect profile of a modified omeprazole-based triple therapy to cure Helicobacter pylori infection. The control group consisted of patients treated with standard dual therapy comprising omeprazole and amoxicillin. One hundred and fifty-seven H. pylori infected patients with duodenal ulcers were randomly assigned to receive either a combination of omeprazole 10 mg, clarithromycin 250 mg and metronidazole 400 mg (OCM) given three times daily for 10 days (n = 81),or a combination of omeprazole 20 mg and amoxicillin 1 g (OA) given twice daily for 14 days (n = 76). Prior to treatment and after 2 and 6 weeks, gastric biopsies from the antrum and corpus were obtained for histology and H. pylori culture. H. pylori infection was cured in 97.4% after OCM and in 65.8% after OA in the per-protocol analysis (p < 0.001) (intention-to-treat analysis: 93.4% and 63.2%, respectively). H. pylori was successfully cultured in 122 patients (77%). The overall rate of metronidazole resistance was 19.7% (24/122), no primary resistance to clarithromycin or amoxicillin was found. In the OCM group, all patients infected with metronidazole-sensitive H. pylori strains (n = 51) and those infected with strains of unknown susceptibility to metronidazole (n = 14)were cured (100%), while 77% (10/13) of those harboring metronidazole-resistant. strains were cured of the infection (p = 0.36). Side effects leading to premature termination of treatment occurred in 2.5% of the patients in the OCM group and in 1.4 % of the OA group. We conclude that combined treatment with omeprazole, clarithromycin and a higher dose of metronidazole is highly effective in curing H, pylori infection, Helicobacter pylori omeprazole and that this regimen remains very effective in the presence of metronidazole resistant strains.

Weitere Episoden von „Medizin - Open Access LMU - Teil 12/22“

• Acneiform dermatoses 1. Januar 1998
• Animal lectins as cell adhesion molecules 1. Januar 1998
• Antimicrobial susceptibility testing of dermatophytes - Comparison of the agar macrodilution and broth microdilution tests 1. Januar 1998
• Application of a novel method for subsequent evaluation of sinusoids and postsinusoidal venules after ischemia-reperfusion injury of rat liver 1. Januar 1998
• Aquarium dermatitis: Cercarial dermatitis in an aquarist 1. Januar 1998
• Beobachtungsstudien im Rahmen eines naturheilkundlichen Klinikverbunds :Teil I: Methoden und Übersicht der Ergebnisse in den beteiligten Kliniken 1. Januar 1998
• Beobachtungsstudien im Rahmen eines naturheilkundlichen Klinikverbunds :Teil II: Detaillierte Ergebnisse der Klinik für Traditionelle ChinesischeMedizin Kötzting 1. Januar 1998
• Beobachtungsstudien im Rahmen eines naturheilkundlichen Klinikverbunds :Teil III: Zwischenergebnisse der diagnosespezifischen Dokumentation Migräne in der Klinik für TraditionelleChinesische Medizin Kötzting 1. Januar 1998
• Beobachtungsstudien im Rahmen eines naturheilkundlichen Klinikverbunds :Teil IV: Methodische Aspekte, Diskussion und Empfehlungen 1. Januar 1998
• Correlation of qEEG with PET in schizophrenia 1. Januar 1998
• Current study concepts for refractory ovarian carcinoma 1. Januar 1998
• Detection of inflammation- and neoplasia-associated alterations in human large intestine using plant/invertebrate lectins, galectin-1 and neoglycoproteins 1. Januar 1998
• Differential treatment of bipolar disorder with old and new antiepileptic drugs 1. Januar 1998
• Diffuse pulmonary hemosiderosis after exposure to pesticides - A case report 1. Januar 1998
• Acetazolamide in the treatment of acute mania - A case report 1. Januar 1998

Alle Episoden von Medizin - Open Access LMU - Teil 12/22 · Mehr Bildung-Podcasts